Matthew Winton, Ph.D. has been appointed chief operations officer, effective April 3, 2023. Dr. Winton most recently served as senior vice president and head of the Multiple Sclerosis franchise for Biogen’s US organization.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on INZY:
